4.8 Article

mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs

期刊

SCIENCE
卷 328, 期 5982, 页码 1172-1176

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1187532

关键词

-

资金

  1. Canadian Cancer Society
  2. Howard Hughes Medical Institute
  3. Terry Fox Foundation
  4. NIH Mouse Models for Human Cancer Consortium [U01 CA84292-06]
  5. Leukemia and Lymphoma Society
  6. Canadian Institutes of Health Research
  7. Alberta Heritage Foundation for Medical Research
  8. Natural Sciences and Engineering Research Council of Canada
  9. Air Force Research Laboratory, Human Effectiveness Directorate, Bioscience and Protection, Wright-Patterson AFB
  10. NIH [R01 DK73802, P50 NS057531]
  11. John and Gladys Strauss Chair in Cancer Research

向作者/读者索取更多资源

The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size. Hence, mTORC1 is implicated in a large number of human diseases-including diabetes, obesity, heart disease, and cancer-that are characterized by aberrant cell growth and proliferation. Although eukaryotic translation initiation factor 4E-binding proteins (4E-BPs) are critical mediators of mTORC1 function, their precise contribution to mTORC1 signaling and the mechanisms by which they mediate mTORC1 function have remained unclear. We inhibited the mTORC1 pathway in cells lacking 4E-BPs and analyzed the effects on cell size, cell proliferation, and cell cycle progression. Although the 4E-BPs had no effect on cell size, they inhibited cell proliferation by selectively inhibiting the translation of messenger RNAs that encode proliferation-promoting proteins and proteins involved in cell cycle progression. Thus, control of cell size and cell cycle progression appear to be independent in mammalian cells, whereas in lower eukaryotes, 4E-BPs influence both cell growth and proliferation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据